Lymphoma News & Leukemia News from Medical News Today

Lymphoma / Leukemia News

Lymphoma / Leukemia News

The latest Lymphoma News & Leukemia News articles published daily. Includes news on blood and lymphatic cancers, Hodgkin's Disease, Epstein-Barr Virus and much more.

Add this Lymphoma rss news feed to your rss reader:

Latest News

Deadly Leukemia Stem Cells Found And Eliminated By New Targeted Therapy

04 July 2009

New research describes a molecular tool that shows great promise as a therapeutic for human acute myeloid leukemia (AML), a notoriously treatment-resistant blood cancer. The study, published by Cell Press in the July 2nd...
[read article]

$500,000 Gruber Genetics Prize Awarded To Cancer Geneticist Janet Davison Rowley

02 July 2009

Janet Davison Rowley, MD, a founder in the field of cancer cytogenetics and a renowned leader in molecular oncology, will receive the 2009 Genetics Prize of The Peter and Patricia Gruber Foundation...
[read article]

Damon Runyon Cancer Research Foundation Awards $2.7M To 7 Top Young Clinical Investigators

01 July 2009

The Damon Runyon Cancer Research Foundation named 4 new Damon Runyon Clinical Investigators at its April 2009 Clinical Investigator Award Committee review. The recipients of this prestigious, three-year award are outstanding...
[read article]

Lymphoma / Leukemia News Articles Archive - Page 1

01 July 2009

CytRx Reports Favorable Progress Update For Its Pivotal Phase 2 Trial With Tamibarotene As A Third-Line Treatment For Acute Promyelocytic Leukemia

30 June 2009

88% Of Chronic Phase Patients With Ph+ CML Who Are Intolerant Or Resistant To Glivec Are Still Alive At 2 Years When Treated With Tasigna

Personalized Anti-Cancer Vaccine, BiovaxID(R), Targeting B-Cell Lymphomas Available In Europe On A Named-Patient Basis

Yaupon Therapeutics Completes Patient Enrollment For Pivotal Phase 2 Study Of Clearazide For Treatment Of Cutaneous T-cell Lymphoma

27 June 2009

Researchers Pinpoint A New Enemy For Tumor Suppressor P53

25 June 2009

Anti-Inflammatory Drugs May Defeat A Treatment-Resistant Type Of Cancer

Mantle Cell Lymphoma Consortium Scientific Workshop - Report From Sixth Annual Meeting Now Available

Acute Lymphoblastic Leukemia, The Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation

24 June 2009

Mesoblast Limited's First Patients In Bone Marrow Transplant Trial Show Earlier Engraftment

BloodCenter Of Wisconsin's New Genetic Test Identifies People At High Risk For Developing Inherited Form Of Leukemia

23 June 2009

Children's Hospital Oakland Scientists First To Discover New Source For Harvesting Stem Cells

21 June 2009

Seattle Genetics Initiates Phase II Trial Of SGN-35 For Anaplastic Large Cell Lymphoma

20 June 2009

Cephalon Provides Clinical Update On Lestaurtinib In Relapsed Acute Myelogenous Leukemia

19 June 2009

The Leukemia & Lymphoma Society Calls For Blood Cancer Research Program At The Department Of Defense

Hodgkin Lymphoma Survivors Have Increased Risk Of Stroke And Transient Ischemic Attack

18 June 2009

Use Of Lenalidomide In Patients With Multiple Myeloma Having Already Received At Least Two Previous Therapies Approved By NICE, UK

Key Found To How Tumor Cells Invade The Brain In Childhood Cancer

Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold In Patients With Late-Stage Leukaemia

16 June 2009

USC Researchers Identify DNA Mutation That Occurs At Beginning Point Of T-Cell Lymphoma

Dual Role In Breast Tissue For A Protein Involved In Leukemia

UPCI Joins ExCell Research Study Using Stem Cells For Leukemia And Lymphoma Patients

13 June 2009

Cancer May Be Stopped In Its Tracks By MicroRNA Replacement Therapy

12 June 2009

Donor Stem Cell Transplantation Associated With Survival Benefit For Patients With Leukemia

09 June 2009

Single Dose Palonosetron Prevents Emesis Induced By Chemotherapy In Non Hodgkin's Lymphoma Patients

Discovery 'Significant Step' In Understanding Leukaemia Drug Resistance

Understanding How A Drug To Treat Acute Lymphoblastic Leukemia Is Degraded

Micromet Presents Update On Blinatumomab's Response Rate And Duration In A Phase 1 Study In Non-Hodgkin's Lymphoma Patients

Afinitor(R) Phase II Data Show Positive Results For Patients With Multiple Types Of Lymphoma, Leading To Phase III Trial

08 June 2009

Memgen Reports Positive Results For ISF35 In High-Risk Chronic Lymphocytic Leukemia

One-Two Drug Punch Knocks Down A Lethal Cancer

Support For Minority Medical Students To Pursue Hematology Research

06 June 2009

Amgen Grant To Study Treatments For Older Leukemia Patients Received By Loyola Fellow

05 June 2009

EpiCept Releases New Data Demonstrating Long-Term Durability Of Ceplene In Sustaining Leukemia-Free Survival

04 June 2009

5 Spanish Centers Join A Study For A New Leukemia And Lymphoma Treatment Technique

New Drug Combination Offers Novel Treatment Strategy For Non-Hodgkin's Lymphoma

03 June 2009

Roswell Park Researchers Evaluate Promising Drug For Intolerant Or Resistant CML

02 June 2009

Positive, Clinically Significant Phase III Results For Personalized Anti-Cancer Vaccine, BiovaxID®, Presented At ASCO Plenary Session

First Viable Treatment Option For Highly Resistant Form Of CML May Be Provided By ChemGenex's Omacetaxine

Trubion Announces Positive Data From A Phase 1 / 2 Study Of TRU-016 For The Treatment Of Chronic Lymphocytic Leukemia (CLL)

Genzyme Receives Positive Opinion For European Approval Of Mozobil

31 May 2009

Gloucester Pharmaceuticals To Present New Data From Two Studies On Romidepsin At ASCO

30 May 2009

FDA Advisory Panel Makes Favorable Recommendation For GlaxoSmithKline And Genmab's ARZERRA(TM) (ofatumumab)

Vion Pharmaceuticals To Present Data On Onrigin(TM)at The ASCO(R) Annual Meeting

Hitting Cancer Where It Hurts

27 May 2009

FDA Grants Full Approval For SPRYCEL For The Treatment Of Adults With Chronic Myeloid Leukemia

Green Tea Extract Shows Promise In Leukemia Trials

25 May 2009

Cole Foundation Injects $2.5 Million To Bolster Leukemia Research

23 May 2009

Another Mystery In B Lymphocyte Development Solved By NYU School Of Medicine Pathology Researchers

22 May 2009

Genentech And Biogen Idec Submit Applications To The FDA For Rituxan For Most Common Type Of Adult Leukemia

20 May 2009

Mutant Genes In High-Risk Childhood Leukemias Identified

19 May 2009

Rituximab Linked To Often Fatal Brain Virus

Xencor To Present Phase 1 Data On XmAb(R)2513 Antibody For Lymphomas At The American Society Of Clinical Oncology Annual Meeting

Collaboration Between NC State And UNC Lineberger To Combat Non-Hodgkin Lymphoma In Human And Canine Patients

18 May 2009

ChemGenex To Present Pivotal Data In T315I Positive CML Patients As Oral Presentation At ASCO

Patients With Aggressive Lymphoma Benefit From Two Targeted Therapies

16 May 2009

Pixantrone Phase 3 Data To Be Presented At The 2009 American Society Of Clinical Oncology (ASCO) Annual Meeting

15 May 2009

Review: Long-term Use Of Lymphoma Drug Extends Lives

Go To News Page:
[1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 [Next] [Last Page]

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Back to front page

List of All Medical Articles

Terms and Conditions


News Archive [link] Web Wikipedia Medical Dictionary [link]

Lymphoma / Leukemia News

Latest News

Lymphoma / Leukemia News Articles Archive - Page 1

Swine Flu Updates